By Ben Hirschler LONDON (Reuters UK) - AstraZeneca AZN shares rose nearly 5 percent on Wednesday after the group won a key U.S. patent battle over its second-biggest selling drug, Seroquel, for schizophrenia and bipolar disorder. The court decision to award summary judgment in its favour,...
Dr. Rob Long--I was greatly distressed to learn that your client Hillary Clinton had stabbed you in the eye with a pencil. As I'm sure you know, the best predictor of violent behavior is past violent behavior, so I was surprised at your lack of precaution with this particular woman....
AstraZeneca wins Seroquel case *The Anglo-Swedish pharmaceutical group AstraZeneca received a boost yesterday when an American court upheld its patent over the $4bn- (2bn) a- year schizophrenia and bipolar blockbuster Seroquel. The New Jersey District Court awarded AstraZeneca summary judgment in the face of...
WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as...
JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug Application ANDA to market its generic version of AstraZeneca's Seroquel[R] Quetiapine Tablets. The Court granted summary...
EL CAJON, Calif., June 20 /PRNewswire/ -- Recently four Charleston, WV-area veterans -- Derek Johnson, 22, Andrew White, 23, Eric Layne, 29, and Nicholas Endicott, with "Post Traumatic Stress Disorder" PTSD, treated with the Paxil, Klonopin, and Seroquel -- died in their sleep. All were said to be...
AstraZeneca's CEO to be Deposed in London on Friday, June 20, 2008 NEW YORK, June 19 /PRNewswire/ -- Weitz & Luxenberg, PC, one of the leading plaintiffs' litigation law firms in America, filed a lawsuit today against pharmaceutical giant AstraZeneca on behalf of a New York City...
ALondon Stock Exchange 1,081p (up 47p, 4.55 per cent) International IPOs in London raised $4.2bn (2.2bn) last month. AAnglo American 3,389p (up 34p, 0.92 per cent) Mining sector strength. AAstraZeneca 2,130p (up 39p, 1.87 per cent) FDA approves Seroquel maintenance treatment in bipolar...
LONDON AFP — Anglo-Swedish pharmaceuticals giant AstraZeneca said Wednesday that the US Food and Drug Administration has approved the use of its Seroquel drug to treat bipolar I disorder. According to AstraZeneca, bipolar I disorder is a lifelong psychiatric condition characterised by manic or mixed mood episodes, interspersed...
WILMINGTON, Del., May 14 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the U.S. Food and Drug Administration FDA has approved SEROQUELR quetiapine fumarate tablets for the maintenance treatment of patients with bipolar I disorder, as adjunct therapy to lithium or divalproex. SEROQUEL is approved by the FDA for the...
WILMINGTON, Del., May 8 /PRNewswire-FirstCall/ -- AstraZeneca today announced the submission of a supplemental New Drug Application sNDA to the U.S. Food and Drug Administration FDA for SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets to seek approval for the treatment of generalized anxiety disorder GAD, including maintenance of antianxiety...
- Studies Evaluated Improvement in Symptoms Both in the Short and Long Term - WILMINGTON, Del., May 5 /PRNewswire-FirstCall/ -- AstraZeneca today announced new study data on SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets for the treatment of major depressive disorder MDD and generalized anxiety disorder GAD...
Seroquel's Successor, Seroquel XR, Will Earn a 16 Percent Patient Share in the Bipolar Disorder Market by 2016, According to a New Report from Decision Resources WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and...
M2 PRESSWIRE-29 February 2008-MB Alerts: AstraZeneca Submits sNDA for SEROQUEL XRTM for the Treatment of Major Depressive DisorderC1994-2008 M2 COMMUNICATIONS LTD RDATE:29022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial...
Simone Roberts THE PBS listing of Seroquel quetiapine fumarate for acute bipolar mania is welcome news for more than 100,000 patients with bipolar disorder. From 1 December, patients with acute mania associated with bipolar 1 disorder can access Seroquel...
Business News IN BRIEF --US health regulators have approved AstraZeneca's Seroquel XR, an extended-release version of one of its top-selling drugs, as a maintenance treatment for adult schizophrenia patients. The basic drug had $3.2bn (1.6bn) revenues in 2006, making it the Anglo- Swedish drug maker's second-biggest...
LONDON, August 29 /PRNewswire/ -- - For International Medical Journalists Only AstraZeneca today announced the Netherlands regulatory authority MEB Medicines Evaluation Board has approved SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets, a once-daily medicine for the treatment of schizophrenia in...
M2 PRESSWIRE-11 July 2007-Biotech News: Trade Alert for AstraZeneca plcC1994-2007 M2 COMMUNICATIONS LTD RDATE:11072007 Trade Alert for AstraZeneca plc (NYSE:AZN) AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory...
The frequently prescribed antipsychotic drugs are causing a slight increase in deaths in demented elderly people, according to a study published recently in Annals of Internal Medicine. You might wonder: Why on earth would a doctor prescribe antipsychotics--drugs that are used to treat schizophrenia and bipolar disorders--to a demented elderly...
Articles 2007-07-01
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
